ArticleJournal of nephropathology2014

Nephrotic syndrome; is rituximab the light at the end of the tunnel in the treatment of adult steroid-dependent minimal change disease and focal segmental glomerulosclerosis?

Andreas Kronbichler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.